| | 
Part, Chapter, Paragraph
1 I, 2. 10. 4(13)| Fact sheet N 275 – Revised 14 November 2006~
2 I, 2. 10. 4(15)| Fact sheet N 275 – Revised 14 November 2006~
3 I, 3. 3 | of the population aged 0-14, 15-64 and 65+. They picture
4 I, 3. 3 | of EU27 population aged 0-14 and 65 or more from 1950
5 I, 3. 3 | be noted:~ ~Children (0-14 years). Bulgaria, Italy,
6 I, 3. 3 | not change much (Figure 14). Poland, Slovakia, Bulgaria,
7 II, 4. 1 | 9.1 years to 23.6 years (14.5 years gap) for men and
8 II, 4. 1 | At 50 the HLY gaps reach 14.5 years for men and 13.7
9 II, 4. 2 | causes of death’ (cause 14 in table 3) across European
10 II, 4. 3 | Journal of Women and Aging 14(1-2): 119-133.~ ~Robine,
11 II, 4. 3 | of Public Health 13(3): 6-14.~ ~Robine, J.-M., C. Jagger,
12 II, 4. 3 | Public Health 2003; 13:6-14.~ ~Robine, J.-M., C. Jagger,
13 II, 5. 2. 3 | diseases (codes ICD-9: 410-14) - Age-standardized (standard
14 II, 5. 2. 3 | diseases (codes ICD-9 410-14) Men aged 35-74 years~ ~
15 II, 5. 2. 3 | diseases (codes ICD-9 410-14) Women aged 35-74 years~ ~
16 II, 5. 2. 6 | from 90,056 participants in 14 randomised trials of statins.
17 II, 5. 2. 6 | Elderly Study). J Hypertens 14: 1159-1166.~Lewington S,
18 II, 5. 3. 6 | Europe-wide trends for 14 childhood cancers were also
19 II, 5. 3. 7 | further details see Chapter 4.14.~ ~
20 II, 5. 3. 8 | Europe we can estimate nearly 14 million of all cancer prevalent
21 II, 5. 3. 9 | third version. Ann Oncol 14(7):973-1005.~ ~Coleman MP,
22 II, 5. 3. 9 | 20th century. Ann Oncol 14 (suppl 5):v128-v149.~ ~ESMO (
23 II, 5. 3. 9 | registry areas. Ann Oncol 14:v28-v40.~ ~Micheli A, Berrino
24 II, 5. 3. 9 | and commentary. Ann Oncol 14 (suppl 5):v61-v118.~ ~Stewart
25 II, 5. 4. 2 | population with a BMI 30 kg/m2~14~ ~HES/HIS Registry~II Epidemiology
26 II, 5. 4. 2 | age/100,000 population 0–14 years~12~HES/HIS Registry~
27 II, 5. 4. 2 | 10: Diabetes mellitus E10–14; HES: Health Examination
28 II, 5. 4. 2 | diabetes in children (0-14 year), with type 1 and 2
29 II, 5. 4. 2 | tested, with HbA1c>7.5%~14~Percent of diabetic subjects
30 II, 5. 4. 2 | profile in the last 12 months~14~Percent of diabetic subjects
31 II, 5. 4. 2 | total cholesterol>5 mmol/l~14~Percent of diabetic subjects
32 II, 5. 4. 2 | measurement in last 12 months~14~Percent of of diabetic subjects
33 II, 5. 4. 2 | subjects who are smoking~14~Percent of diabetic subjects
34 II, 5. 4. 3 | diabetes in children (0-14 year). Standardised incidence
35 II, 5. 4. 3 | and 2.4% (1.0-3.8%) for 10-14 years (Green, 2001).~Prevalence
36 II, 5. 4. 3 | in crude percentages of 14% (Ireland) to 68% (Cyprus)
37 II, 5. 4. 3 | ranging between 1% and 14%.~Indicator on timely laser
38 II, 5. 4. 4 | with a median value of 14%. The problem increases
39 II, 5. 4. 6 | According to the IDF, among the 14 countries with no plan,
40 II, 5. 4. 8 | Nutrition and Metabolism 2001;14(2), 100-103.~Carinci M,
41 II, 5. 4. 8 | Proc Natl Acad Sci U S A. 14;104(33):13225-31~TRIG p (
42 II, 5. 5. 1 | citizens, 45 000 men and 14 000 women committed suicide
43 II, 5. 5. 1 | any anxiety disorder was 14%. Table 5.5.1.1 presents
44 II, 5. 5. 1 | respectively.~ ~In the 0-14 age group (Table 5.5.1.8)
45 II, 5. 5. 1 | suicide in the world with 14 per 100 000 (WHO statistics).~ ~
46 II, 5. 5. 1 | Epidemiol Psichiatr Soc 17(1):14-9.~ ~S H et al. (2006).
47 II, 5. 5. 1 | Qual Life Res 15(8):1403-14.~ ~Schmidtke A., Bille-Brahe
48 II, 5. 5. 2 | Ferri et al analysed the 14 WHO worlds regions but for
49 II, 5. 5. 3 | categories are observed 0 to 14 years and 15 to 19 years.
50 II, 5. 5. 3 | separately in age group 0-14).~Finland~ ~X~ ~France~ ~
51 II, 5. 5. 3 | incidence rate among 10-14-year-old females has risen
52 II, 5. 5. 3 | article online, accessed on 14 February 2008).~The Cleveland
53 II, 5. 5. 3 | follows:~Mini survey Finland 14.3%~NEMESIS Netherlands 53.
54 II, 5. 5. 3 | last accessed Dec 14, 2007.~Wrigley S, Jackson
55 II, 5. 5. 3 | children born in 1994 from 14 states. A total of 407,578
56 II, 5. 5. 3 | common etiological factors (14-21%) followed by trauma (
57 II, 5. 5. 3 | Tidman et al., 2003 (*)~+ = 5-14 years - = 6-12 years MR =
58 II, 5. 5. 3 | Pediatricians ~ = 6-16 years Ø = 6-14 years GP = General practitioners
59 II, 5. 5. 3 | policies~Prevalent cohort~32~14.6~2.2~Svensson and Astrand,
60 II, 5. 5. 3 | epilepsy during the first 10 to 14 years of disease. Generalised
61 II, 5. 5. 3 | up prospectively over 11-14 years. J Neurol Neurosurg
62 II, 5. 5. 3 | greater proportion) costs €14 300 per year, €31 200 per
63 II, 5. 5. 3 | but accounted for only 14% of the variation between
64 II, 5. 5. 3 | at: htt rg Accessed June 14 2005.~Granieri E, Malagú
65 II, 5. 5. 3 | in: Mult Scler. 2008 May;14(4):574.~Sumelahti ML, Tienari
66 II, 5. 5. 3 | specific foods. Mov Disord 14(1):21-27.~Andlin-Sobocki
67 II, 5. 5. 3 | analysis. Pharmacoeconomics 14(3):299-312.~Dorsey ER, Constantinescu
68 II, 5. 5. 3 | Aragon, Spain. Mov Disord 14(4):596-604.~EuroPa Consortium (
69 II, 5. 5. 3 | southeastern Sweden. Mov Disord. 14:28-37.~ ~Findley L, Aujla
70 II, 5. 6. 4 | with sick leave longer than 14 days due to musculoskeletal
71 II, 5. 6. 6 | for Europe, Copenhagen, 11-14 September 2006. Available
72 II, 5. 7. 3 | ESRD in children aged 0-14 was 7.1 patients pmarp (
73 II, 5. 7. 3 | prevalence of RRT in the 0-14 years age group was 43 per
74 II, 5. 7. 3 | stage 1-5 CKD rose from 14.5% (NHANES III) to 16.8% (
75 II, 5. 7. 3 | 65+ age group. In the 0-14 age group, however, the
76 II, 5. 7. 3 | 72% for patients aged 0-14, 15-64 and over 65 years
77 II, 5. 7. 5 | approach to the problem {14 National Kidney Foundation,
78 II, 5. 7. 7 | JAMA 2003;290(23):3101-14.~Chadban SJ, Briganti EM,
79 II, 5. 7. 7 | study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-S138.~Chen
80 II, 5. 7. 7 | Am Soc Nephrol 2003 Oct;14(10):2573-80.~Loucks EB,
81 II, 5. 8. 2 | among asthmatic patients, 14% in Po Delta and 11% in
82 II, 5. 8. 2 | emphysema, 31% in Po Delta and 14% in Pisa also reported asthma (
83 II, 5. 8. 3 | disease in 40-69 year olds to 14.4% (6.3% COPD) (Murtagh
84 II, 5. 8. 7 | Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer L, Lamprecht
85 II, 5. 9. 2 | 304 679 children aged 13–14 years from 106 centres in
86 II, 5. 9. 2 | years from 29 centres in 14 countries (mostly European).
87 II, 5. 9. 3 | Figure 5.9.3. Asthma by age 14 years in ECHRS and ISAAC
88 II, 5. 9. 3 | prevalence in children, 14.7% in adolescents, while
89 II, 5. 9. 3 | 16.9% in children of 13.14 years of age), Romania (
90 II, 5. 9. 3 | while adolescents 13 to 14 years old presented a 37.
91 II, 5. 9. 3 | Romania 15%, Switzerland 14.2% in adults and 17% in
92 II, 5. 9. 3 | age-group than in the 13–14 years of age-group: for
93 II, 5. 9. 3 | no changes); for the 13–14 years of age-group, 11 of
94 II, 5. 9. 3 | emergency room treatment was 14-18%. Nevertheless, in different
95 II, 5. 9. 4 | 1450 children aged 13- to 14- and living in Brescia,
96 II, 5. 9. 4 | clinical asthma among 13- to 14-yr-old adolescents seem
97 II, 5. 9. 7 | fever, and eczema in 12-14 year olds in the British
98 II, 5. 10. 7 | 310, 28.11.2007, pp. 11–14.~ ~European Food Safety
99 II, 5. 11. 3 | General Internal Medicine 1999;14(6):379–385.~B Larsson-Stymne,
100 II, 5. 11. 3 | per 100 000 for SCC and 14 per 100 000 for melanoma (
101 II, 5. 11. 7 | Prev Soc Med 1976;30:107–14.~ ~Ryan TJ (1991): Disability
102 II, 5. 12. 7 | liver cirrhosis mortality in 14 European countries. Addiction
103 II, 5. 14 | 5.14 Dental and oral diseases~ ~
104 II, 5. 14. 1 | 5.14.1 Introduction~ ~Oral disease
105 II, 5. 14. 2 | 5.14.2 Data sources~ ~ ~Data
106 II, 5. 14. 3 | 5.14.3 Data description and analysis~ ~
107 II, 5. 14. 3 | severity (DMFT). (Table 5.14.1). For instance, the actual
108 II, 5. 14. 3 | is 1.0 DMF-T.~ ~Table 5.14.1. Dental Health in 12 year-old
109 II, 5. 14. 3 | loss in Europe (Figure 5.14.1). Edentulous prevalence
110 II, 5. 14. 3 | the future.~ ~ ~Figure 5.14.1. Edentulous people aged
111 II, 5. 14. 3 | 15% of adults (Figure 5.14.2). According to the results
112 II, 5. 14. 3 | and 4% severe.~ ~Figure 5.14.2. Adults aged 35-44 with
113 II, 5. 14. 3 | health services. Figure 5.14.3 illustrates the difference
114 II, 5. 14. 3 | the age of12.~ ~Figure 5.14.3. Children aged 12 with
115 II, 5. 14. 4 | 5.14.4. Risk factors~ ~The caries
116 II, 5. 14. 5 | 5.14.5. Control tools and policies~ ~
117 II, 5. 14. 6 | 5.14.6. Policies~ ~At the 60th
118 II, 5. 14. 7 | 5.14.7. Future developments~ ~
119 II, 5. 14. 8 | 5.14.8. References~ ~Bourgeois
120 II, 6. 3. 4 | observed among children aged 0–14 years. In all, the peak
121 II, 6. 3. 4 | overall, while children under 14 represented 4%. Mean age
122 II, 6. 3. 5 | by the under-4 age group (14.1 per 100 000), while the
123 II, 6. 3. 5 | the youngest age groups (0–14 years).~ ~In 2005, a total
124 II, 6. 3. 6 | yersiniosis with Lithuania (14.63 per 100 000) followed
125 II, 6. 3. 6 | toxoplasmosis cases were reported by 14 countries, with Lithuania (
126 II, 6. 3. 6 | 000), followed by Iceland (14.65 per 100 000) reported
127 II, 6. 3. 6 | age groups are children 5–14 years of age and adults
128 II, 6. 3. 6 | a mean survival of about 14 months. The main suspected
129 II, 6. 3. 7 | 65%), followed by Greece (14%). In 2005, 21 countries
130 II, 7. 3. 4 | injury sector (Figure 7.14).~ ~Figure 7.14. Non fatal (
131 II, 7. 3. 4 | Figure 7.14).~ ~Figure 7.14. Non fatal (hospital treated
132 II, 7. 4. 4 | activities (see Figure 7.14).This means that an annual
133 II, 8. 1. 3 | considerable limitations and about 14% of those limited to some
134 II, 8. 2. 1 | across Europe. A set of 14 Country Reports gives considerable
135 II, 8. 2. 1 | followed up to the age of 14 in Northern Finland. It
136 II, 8. 2. 1 | intellectual disabilities in 14 participating countries (
137 II, 8. 2. 1 | surveyed current practices in 14 European countries and made
138 II, 9. 1. 1 | Paediatr Perinat Epidemiol 14(3):194-210.~ ~Kramer MS,
139 II, 9. 1. 1 | Health Stat Q 2004(24):14-22.~Olausson PM, Cnattingius
140 II, 9. 1. 2 | Congenital Malformations in 14 Regions of Europe”, Prenatal
141 II, 9. 2. 2 | produced for those aged 0-14 years inclusive, or those
142 II, 9. 2. 2 | group. Using a cut-off at 14 years excludes an important
143 II, 9. 2. 2 | generally being those aged 0-14 years (from birth to early
144 II, 9. 2. 3 | 2), and accidents for 5-14 year olds (see Chapter 7).~ ~
145 II, 9. 2. 3 | cancer in children aged 0-14 in selected EUGLOREH Countries –
146 II, 9. 2. 3 | cancer in children aged 0-14 in selected EUGLOREH Countries –
147 II, 9. 2. 3 | symptoms” for children aged 13-14 for those countries which
148 II, 9. 2. 3 | clinical asthma2 in 13- to 14-year-old children as high
149 II, 9. 2. 3 | 15.3% for England, and 14.6% in Ireland, which rank
150 II, 9. 2. 3 | death in children aged 1-14 in Europe. Over 40% of 11–
151 II, 9. 2. 3(2) | 12-month period in 13- to 14-year-old children) was used
152 II, 9. 2. 7 | Available at:~htt ml accessed 14.01.07~ ~UNICEF (2002): Young
153 II, 9. 3. 1 | in Psychiatric Treatment 14: 256-262~ ~Braun, M., Wassner,
154 II, 9. 3. 2 | Paediatr Perinat Epidemiol 2000;14(3):194-210.~ ~Langer B,
155 II, 9. 3. 2 | Health Stat Q 2004(24):14-22.~ ~Marret S, Ancel PY,
156 II, 9. 3. 3 | sexuality in the age group of 14 to 17 year olds and their
157 II, 9. 3. 3 | Representative survey of 14 to 17- year-olds and their
158 II, 9. 4. 3 | by the population aged 0-14 years [per 100]) shows that
159 II, 9. 5. 4 | Reference A6-0199/2005 : 14/09/2006~· Promoting health
160 II, 9. 5. 6 | Health selection in a 14-year follow-up study - a
161 III, 10. 1. 3 | system provides lessons 14 years on. BMJ 331:234-235.~
162 III, 10. 1. 3 | children. J Public Health 14(2):71-75.~Wagner N, Meusel
163 III, 10. 2. 1 | their mouth approximately 11-14 hours per day (ENSP, 2003).~ ~
164 III, 10. 2. 1 | 2003). Annals of Oncology; 14: 973–1005. Available at: htt ~ ~
165 III, 10. 2. 1 | Some 53 million adults (14% of the adult population
166 III, 10. 2. 1 | effectiveness - Main report (PHIAC 14.3a). Available at: htt ~ ~
167 III, 10. 2. 1 | Journal of Public Health Vol. 14(2):103-109.~ ~Greyling T
168 III, 10. 2. 1 | Journal of Public Health, 14(1):1–10.~ ~Sobal J, Stunkard
169 III, 10. 2. 1 | measured weight and height, 14.1% of Cypriot (Savva et
170 III, 10. 2. 1 | Enghardt-Barbieri, 2004) and of 14.5% in the Netherlands (2-
171 III, 10. 2. 1 | Czech Republic (9.0%, both sexes 14-17 years old) (Lobstein
172 III, 10. 2. 1 | boys (17.0%) than girls (14.3%) being overweight. The
173 III, 10. 2. 1 | overweight in adolescents aged 13-14 more than doubled from 1985
174 III, 10. 2. 1 | Council Resolution of 14 December 2000 on health
175 III, 10. 2. 1 | Obesity (Silver Spring): 14:2054-2063.~ ~Wang Y, Lobstein
176 III, 10. 2. 4 | journal paper which covered 14.000 cases and 3000 shared
177 III, 10. 2. 4 | Genome-wide association study of 14,000 cases of seven common
178 III, 10. 3. 1 | million children (age 0-14) per year. Whether changes
179 III, 10. 3. 2 | increased by an average of 14% a year between 2000 and
180 III, 10. 3. 2 | released into water bodies (-14.5%), the various types of
181 III, 10. 3. 2 | public health problems. 14 of the 16 European companies
182 III, 10. 3. 3 | a mean survival of about 14 months. The main suspected
183 III, 10. 3. 4 | the Upper Danube and up to 14% for the Meuse catchment.
184 III, 10. 4. 1 | substantial risk to health. For 14% of people, the European
185 III, 10. 4. 1 | Berlin, Copenhagen, Rome, 14 April 2005.~ ~WHO (2005):
186 III, 10. 4. 2 | agents (see also Section 4.14.2).~ ~Apart from Regulation
187 III, 10. 4. 2 | tolerable weekly intake (TWI) of 14 pg WHO-TEQ/kg body weight
188 III, 10. 4. 2 | applied increased by only 14% and 25% respectively during
189 III, 10. 4. 2(37)| and vegetables (OJ L 350,14.12.1986, p 71).~
190 III, 10. 4. 2 | end, consumption data from 14 MS, 41 diet sets for different
191 III, 10. 4. 2 | and requirements (Article 14 to 21), already existing
192 III, 10. 4. 2 | European Communities No. L 043, 14 February 1997. Available
193 III, 10. 4. 2 | European Communities No. L 83/14, 22 March 2006.~Available
194 III, 10. 4. 2 | Official Journal L 350 , 14/12/1990. Available at:~htt ~ ~
195 III, 10. 4. 2 | methods and approaches” 13-14 July 2006. 155.~ ~EFSA (
196 III, 10. 4. 2 | micro-organisms in food and feed. 13-14 December 2004. pp. 142.
197 III, 10. 4. 3 | 000 children aged under 14 years die annually due to
198 III, 10. 4. 5 | On average, this equals 14 tonnes/capita but there
199 III, 10. 4. 5 | Estonia military sites cover 14 % of the total investigated
200 III, 10. 5. 2 | prevalence was higher in urban (14.2%) than in rural settings (
201 III, 10. 5. 3 | by absence. E.g. whereas 14% of women working in agriculture
202 III, 10. 5. 3 | those working part-time. 14.5% of them hold a contract
203 III, 10. 5. 3 | economic sectors (table 10.5.3.14). Especially employees working
204 III, 10. 5. 3 | per gender.~ ~Table 10.5.3.14. Physical risks factors
205 III, 10. 5. 3 | relating to machinery~- 2000/14/EC: approximation of the
206 III, 10. 6. 1 | Possible score range from 3 to 14. Scores 3-8 are considered
207 III, 10. 6. 1 | social support and scores 12-14 strong social support.~ ~
208 III, 10. 6. 1 | 11 EU Member States and 14 EU countries participated
209 IV, 11. 1. 2(1) | Health Accounts in 2006 for 14 OECD countries. More information
210 IV, 11. 1. 6 | payments for immunization), 14% by fee-for-service for
211 IV, 11. 5. 3 | Figures from 11.11 to 11.14.~ ~Figure 11.11. Organ Procurement
212 IV, 11. 5. 3 | European countries~Figure 11.14. Percentage and absolute
213 IV, 11. 6. 2 | inpatient stays longer than 14 days in Germany or 28 days
214 IV, 11. 6. 4 | insurance funds (Table 11.14), the resources generated
215 IV, 11. 6. 4 | et al 2007).~ ~Table 11.14. Collection and allocation
216 IV, 11. 6. 4 | fund allocates~*~ ~Denmark~14 counties and the State~Each
217 IV, 11. 6. 4 | State allocates to counties.~14 regional councils~Age, children
218 IV, 11. 6. 5 | Academy of Management Review 14 ,(4): 57-74.~ ~Epstein AM,
219 IV, 11. 6. 5 | Canadian Journal on Aging . 14(2): 360-390.~ ~Figueras
220 IV, 11. 6. 5 | and Safety in Health Care 14(1): 4-5.~ ~Marshall MN,
221 IV, 12. 3 | the EU and covering some 14.5 million employees;~· public
|
|
| |
